B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics - Archive ouverte HAL
Article Dans Une Revue Annals of the Rheumatic Diseases Année : 2021

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Emmanuel Chatelus
Laurent Arnaud
Jean Sibilia
  • Fonction : Auteur
  • PersonId : 1042337
Nicolas Meyer
  • Fonction : Auteur
  • PersonId : 878759
Martin Soubrier

Résumé

No abstract available

Dates et versions

hal-03606627 , version 1 (11-03-2022)

Identifiants

Citer

Renaud Felten, Pierre-Marie Duret, Elodie Bauer, Nathanael Sedmak, Julien H. Djossou, et al.. B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics. Annals of the Rheumatic Diseases, 2021, ⟨10.1136/annrheumdis-2021-220549⟩. ⟨hal-03606627⟩
55 Consultations
0 Téléchargements

Altmetric

Partager

More